Latest KFF Health News Stories
Watch: Defining The Debate On Health Care Coverage Options
Politicians are throwing around a lot of terms when they talk about their health care plans: universal care, “Medicare for All,” “Medicare Buy-In.” KHN helps explain what they are talking about.
Going Down Fighting: Dying Activist Champions ‘Medicare For All’
Presidential hopeful Elizabeth Warren tried to tell the story of Ady Barkan in the latest Democratic debate. He’s one of the most prominent advocates for “Medicare for All” and is spending his remaining time alive doing everything he can to make the case that all Americans need affordable health coverage.
Trump Administration Hits Brakes On Law To Curb Unneeded Medicare CT Scans, MRIs
Critics worry the delays come at a steep cost: Medicare paying for millions of unnecessary exams and patients subject to radiation for no medical benefit.
Para ahorrar dinero, pacientes y cirujanos se encuentran en Cancún
El turismo médico no es un fenómeno nuevo. Pero sí lo son las compañías que contratan médicos estadounidenses para que viajen al exterior a operar a pacientes de los Estados Unidos.
Class-Action Lawsuit Seeks To Let Medicare Patients Appeal Gap in Nursing Home Coverage
Medicare beneficiaries under observation care in the hospital can face higher costs for treatment and are not covered for nursing home care when discharged. A federal trial in Hartford, Conn., will determine whether the government’s ban on appeals involving observation care coverage is fair.
To Save Money, American Patients And Surgeons Meet In Cancun
The patient is from Mississippi. The surgeon is from Wisconsin. They meet in a Mexican resort for knee replacement surgery. Because the care costs so much less than in the U.S, the patient’s health plan pays her $5,000.
Where Tourism Brings Pricey Health Care, Locals Fight Back
Residents in Colorado ski resort country found relief from high insurance premiums and high hospital costs by joining forces and negotiating prices directly with the local hospital.
KHN’s ‘What The Health?’: Gun Violence And The Politics Of Public Health
The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
Recomendación sobre la vacuna contra el VPH para adultos puede generar confusión
El virus del papiloma humano es la infección de transmisión sexual más común en los Estados Unidos; casi todas las personas sexualmente activas lo contraerán en algún momento.
Price Of Snakebite Drug Is Sky High, But New Competitor Unlikely To Lower Costs
The drug CroFab, which has been on the market since 2000, now faces competition from a drug called Anavip. But both are expensive.
Federal Experts’ Advice On HPV Vaccine Could Leave Adults Confused
A federal advisory panel says people between ages 27 and 45 may benefit from the vaccine to fight the human papillomavirus. But some public health advocates worry that the advice doesn’t provide doctors and patients clear guidance about who in this large age group are good candidates for the vaccine.
Doctors Argue Plans To Remedy Surprise Medical Bills Will ‘Shred’ The Safety Net
A case of questionable logic.
Watch: What Happened To That $500K Dialysis Bill
After journalists investigate, Fresenius, one of the largest dialysis providers in the U.S., has agreed to waive a half-million-dollar bill. Sovereign Valentine, from Plains, Mont., said it’s a “huge relief.”
Estrellas del deporte popularizan terapias con células madre que no están probadas
Médicos están preocupados por el mensaje equivocado que se está enviando sobre estos tratamientos que, dicen, no están probados y realmente no aceleran los procesos de recuperación.
Drugmakers Master Rolling Out Their Own Generics To Stifle Competition
Known as “authorized generics,” in-house spinoffs of brand-name drugs quietly undermine the competition.
Superstar Athletes Popularize Unproven Stem Cell Procedures
Treatments for baseball pitcher Max Scherzer and other pros may mislead fans about costly, controversial, unapproved stem cell shots.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Infusion Treatments — Needed or Not — Can Deplete Patients’ Wallets
When it comes to physician-administered infusion drugs, doctors sometimes have a financial reason for their choice and patients often aren’t aware of cheaper options.
KHN’s ‘What The Health?’: Deciphering The Democrats’ Health Debate
Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHN’s Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.
Proyecto en California combatiría acuerdos que atrasan salida al mercado de genéricos
La FTC ha estimado que los acuerdos de pago por retraso le cuestan a los consumidores y contribuyentes estadounidenses $3.5 mil millones, en costos más altos de medicamentos cada año.
